Table 5.

COMPARISON OF EARLY AND LATE MORTALITY IN 139 PATIENTS WITH HCC RECEIVING HCC TREATMENTS

Treatment Modality	No. Patients	Hazard Ratio	95% CI	P Value
A. Early follow‐up (<3 years)
OLT/no prior recurrence or residual	19	1.00	Reference	Reference
OLT/prior recurrence	16	2.53	0.90‐7.13	0.0790
OLT/prior residual	15	1.83	0.61‐5.52	0.2850
Resection	52	1.82	0.69‐4.83	0.2280
RFA	44	1.96	0.68‐5.63	0.2100
TACE	53	7.90	3.43‐18.22	0.0000
PEI	8	7.90	3.43‐18.22	0.0000
Chemotherapy	18	28.38	10.38‐77.57	0.0000
Resection vs. OLT/prior recurrence		0.72	0.29‐1.82	0.4890
Resection vs. OLT/prior residual		1.00	0.37‐2.71	0.9950
RFA vs. OLT/prior recurrence		0.78	0.29‐2.10	0.6170
RFA vs. OLT/prior residual		1.07	0.37‐3.13	0.8970
TACE vs. OLT/prior recurrence		3.13	1.42‐6.90	0.0050
TACE vs. OLT/prior residual		4.31	1.79‐10.44	0.0010
RFA vs. Resection		1.08	0.45‐2.56	0.8670
TACE vs. Resection		4.34	2.30‐8.17	0.0000
TACE vs. RFA		4.03	1.90‐8.52	0.0000
B. Late follow‐up (≥3 years)
OLT/no prior recurrence or residual	19	1.00	Reference	Reference
OLT/prior recurrence	16	2.53	0.90‐7.13	0.0790
OLT/prior residual	15	1.83	0.61‐5.52	0.2850
Resection	52	6.56	2.52‐17.05	0.0000
RFA	44	6.46	2.21‐18.83	0.0010
TACE	53	7.90	3.43‐18.22	0.0000
PEI	8	7.90	3.43‐18.22	0.0000
Chemotherapy	18	28.38	10.38‐77.57	0.0000
Resection vs. OLT/prior recurrence		2.60	1.03‐6.55	0.0430
Resection vs. OLT/prior residual		3.59	1.28‐10.07	0.0150
RFA vs. OLT/prior recurrence		2.55	0.91‐7.16	0.0750
RFA vs. OLT/prior residual		3.53	1.14‐10.91	0.0280
TACE vs. OLT/prior recurrence		3.13	1.42‐6.90	0.0050
TACE vs. OLT/prior residual		4.32	1.79‐10.44	0.0010
RFA vs. Resection		0.98	0.42‐2.28	0.9710
TACE vs. Resection		1.20	0.56‐2.60	0.6340
TACE vs. RFA		1.22	0.49‐3.03	0.6620

Abbreviations: OLT, orthotopic liver transplantation; PEI, percutaneous ethanol injection.